SYNSAM Synsam AB (publ)

5.955USD60.50 SEK · STO-1.79%Mkt Cap: 832.99M USDP/E: 16.09

Synsam AB (publ), together with its subsidiaries, operates in the optical retail and eye health sector in the Nordic Region. The company offers lenses, frames, sunglasses, sports spectacles, contact lenses, eye care acce…

Key Statistics

Company
Market Cap832.99M USD
Enterprise Value1.14B USD
Revenue (TTM)739.11M USD
Gross Profit529.45M USD
Net Income (TTM)44.69M USD
Revenue/Share5.20 USD
Last Price5.955 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees5.6K
CountrySE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINSE0016829709
Valuation
P/E (Trailing)16.09
P/E (Forward)15.13
PEG—
EV/EBITDA8.70
EV/Revenue1.55
P/S1.13
P/B3.17
EPS (TTM)0.37 USD
EPS (Forward)0.39 USD
52W Range
4.90248% of range7.097
52W High7.097 USD
52W Low4.902 USD
Profitability
Gross Margin74.71%
Oper. Margin12.27%
EBITDA Margin17.78%
Profit Margin6.31%
ROE18.64%
ROA5.71%
ROIC12.29%
ROCE14.04%
Growth
Revenue Growth9.90%
Earnings Growth-28.50%
Cash Flow & Leverage
Operating CF124.61M USD
CapEx (TTM)31.20M USD
FCF Margin9.40%
FCF Yield8.34%
Net Debt305.62M USD
Net Debt/EBITDA2.33
Net Debt/FCF4.40
Balance Sheet
Debt/Equity1.46
Current Ratio1.06
Quick Ratio0.49
Book Value/Sh1.88 USD
Cash/Share0.38 USD
Dividends
Fwd Div Rate0.18 USD
Trail. Div Rate0.18 USD
Div. Yield2.92%
5Y Avg Yield3.41%
Payout Ratio47.87%
Ex-Div DateApr 23, 2026
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)7.579 USD
Upside (mean)+27.3%
Target Range6.103 USD – 8.563 USD
6.103+27.3% to mean8.563
# Analysts4
Ownership
Shares Out.139.88M
Float106.60M
Insiders25.02%
Institutions59.54%
Technical
SMA 505.440 (+9.5%)
SMA 2005.732 (+3.9%)
Beta0.55
S&P 52W Chg12.00%
Avg Vol (30d)210.19K
Avg Vol (10d)246.61K
Technical Indicators
RSI (14)61.2
MACD1.8376
MACD Signal1.6844
MACD Hist.+0.1532
BB Upper6.271 USD
BB Middle5.775 USD
BB Lower5.280 USD
BB Width17.16%
ATR (14)0.1489 USD
Vol Ratio (20d)0.57x

About Synsam (STO: SYNSAM)

›

Synsam (STO: SYNSAM) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 5,600 employees.

The shares were at 60.50 SEK on 19 November 2026, down 0.6% over 52 weeks. Its 52-week range is 49.80 SEK to 72.10 SEK: the price is 16.1% below the high and 21.5% above the low.

At a market capitalisation of 8.46B SEK, it trades at 16.1 times trailing earnings and 15.1 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 49.2, a discount of 67% for SYNSAM. It pays a dividend yielding 2.92% (it pays out 48% of its earnings), against a median of 0.93% among the dividend payers in that peer group.

Synsam reports return on equity of 18.6%, an operating margin of 12.3% and revenue up 9.9% year over year.

Its debt exceeds its cash by 3.11B SEK, a debt-to-equity ratio of 1.46. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 4 analysts cover the stock, with an average rating of Buy; their mean price target of 77.00 SEK is 27.3% above the current price. The next earnings report is expected on 18 February 2027.